Skip to content

Clinical trials

Lupus Erythematosus, Systemic trials in Belgium

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Lupus Erythematosus, Systemic Country / region: Belgium Clear all

49 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20053
20061
20073
20083
20105
20112
20123
20133
20152
20171
20181
20192
20202
20213
20224
20233
20242
20253
20263

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed23
Active, not recruiting8
Terminated7
Recruiting6
Enrolling by invitation2
Not yet recruiting1
Unknown status1
Withdrawn1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
UCB Pharma9
AstraZeneca4
Bristol-Myers Squibb4
Biogen3
GlaxoSmithKline3
Human Genome Sciences Inc., a GSK Company3
UCB Biopharma SRL3
Cephalon, Inc.2
Eli Lilly and Company2
Juno Therapeutics, Inc., a Bristol-Myers Squibb Company2

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Lupus Erythematosus, Systemic49
Autoimmune Diseases9
Arthritis, Rheumatoid8
Lupus Nephritis4
Connective Tissue Diseases3
Immune System Diseases3
Scleroderma, Systemic3
Arthritis, Juvenile2
Myositis2
Scleroderma, Diffuse2

Trials

Showing 26 to 49 of 49. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.